Enter your login e-mail to the account
Search
Search parameters
Search results
- AGE RELATED MACULAR DEGENERATION – RISK FACTORS AND TREATMENT
prof. MUDr. Andrej Černák, DrSc., MUDr. Martin Černák, MUDr. Branislav Trnavec
(6/2008, Consilium ) - RANIBIZUMAB – NEW OPTION IN TREATMENT OF AGE RELATED MACULAR DEGENERATION
MUDr. Martin Černák, PhD., prof. MUDr. Andrej Černák, DrSc.
(11/2008, Medicine )
- The use of monoclonal antibodies in neurology
prof. MUDr. Egon Kurča, PhD., MUDr. Mária Cuninková
(6/2011, Main topic ) - Diabetic Neuropathy – Neurologist Perspective
MUDr. Tomáš Nedělka, doc. MUDr. Martin Bojar, CSc., MUDr. Radim Mazanec, Ph.D.
(6/2009, Review articles )
- Lung cancer in elderly
doc. MUDr. Mária Wagnerová, CSc.
(1/2007, Review articles ) - mTOR inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Radovan Barilla, PhD., MUDr. Zuzana Syčová-Milá
(1/2009, Review articles ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - New insights into the pathophysiology of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(1/2013, Editorial ) - Adjuvant chemotherapy of colorectal cancer
MUDr. Vanda Ušáková, PhD., RNDr. Zdena Bartošová, CSc.
(3/2011, Review articles ) - Myelodysplastic syndrome – classification, pathophysiology
prof. MUDr. Elena Tóthová, CSc.
(1/2014, Spectrum ) - New mechanism of action in the treatment of renal cell carcinoma: m-TOR – a novel target
MUDr. Hana Študentová, prof. MUDr. Bohuslav Melichar, Ph.D.
(5/2010, Review articles ) - First line treatment of metastatic renal cell cancer in 2014
MUDr. Mária Rečková
(4/2014, Main topic ) - Treatment of metastatic clear cell renal cell carcinoma after failure of first-line treatment
MUDr. Marián Streško, PhD.
(4/2014, Main topic ) - Multipotent cell-mediated drug resistance
doc. MUDr. Štefan Polák, CSc., Mgr. Lucia Kučerová, PhD., RNDr. Lenka Baranovičová, Mgr. Svetlana Školeková, MUDr. Martin Boháč
(4/2013, Review articles ) - BIOPHARMACEUTICALS IN ONCOLOGY
doc. PharmDr. Juraj Sýkora, CSc.
(3/2008, Review articles ) - A case of a patient developed an acute coronary syndrome during the treatment with Bevacizumab
MUDr. Mária Rečková, Prof. MUDr. Beata Mladosievičová, CSc., MUDr. Barbora Piteková
(5/2015, Original articles & case reports ) - Hepatocellular carcinoma in children a adolescents – differences in comparison with the hepatology in adults
MUDr. Viera Bajčiová, CSc.
(4/2010, Review articles ) - New trends in diagnosis and treatment of essential thrombocythemia and myelofibrosis
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2012, Review articles ) - Ribociclib, inhibitor of cyclin-dependent kinases 4 and 6, in the treatment of HR+/HER2 - advanced breast cancer
MUDr. Mária Rečková
(1/2017, Drugs & drug classes ) - Temsirolimus – mTOR as a new target for the treatmet of advanced cell carcinoma (RCC) and relapsed and/or refractory mantle cell lymphoma (MCL)
doc. PharmDr. Juraj Sýkora, CSc.
(5/2009, Drugs & drug classes ) - Systemic treatment of metastatic renal cell carcinoma after failure of the first line of treatment
MUDr. Dagmar Sudeková
(1/2018, Main topic )
- Potential use of mesenchymal stem cell-derived exosomes in the treatment of androgenic alopecia in women
MUDr. Daniela Pavlusová, Mgr. Pavla Boháčová, doc. MUDr. Monika Arenbergerová, Ph.D.
(3/2021, Review articles )
- Retinal vein occlusion
prof. MUDr. Peter Kubisz, DrSc., MUDr. Juraj Chudej, MUDr. Juraj Sokol, MUDr. Radoslava Šimonová1, MUDr. Katarína Kabačová, doc. MUDr. Ján Staško, PhD., mim. prof.
(3-4/2012, Review articles ) - Microcirculation in intestinal mucosa and its conextion to IBD
MUDr. Petronela Bušíková, PhD., doc. MUDr. Ján Porubský, CSc.
(3-4/2012, Review articles ) - XXI. SLOVENSKO-ČESKÁ KONFERENCIA O HEMOSTÁZE A TROMBÓZE S MEDZINÁRODNOU ÚČASŤOU
(S2/2014, Supplement )